Full-Time

Tax Manager

Updated on 11/20/2024

Roivant Sciences

Roivant Sciences

201-500 employees

Develops biopharmaceuticals and RNA therapeutics

Biotechnology
Healthcare

Compensation Overview

$147k - $167kAnnually

+ Bonus + Equity

Mid, Senior

New York, NY, USA

Category
Financial Accounting
Tax Accounting
Accounting
Requirements
  • Bachelor’s degree in Accounting, Finance, or a related field. Master’s degree or CPA certification preferred.
  • Minimum of 5-7 years of experience in tax management or a similar role, preferably in a corporate environment.
  • Proficiency in OneSource Tax Provision software.
  • In-depth knowledge of federal, state, and local tax laws and regulations.
  • Strong analytical skills with the ability to interpret complex tax issues and provide strategic recommendations.
  • Excellent communication and interpersonal skills, with the ability to collaborate effectively with internal and external stakeholders.
Responsibilities
  • Review preparation of federal, state, and local tax returns and information reporting.
  • Ensure timely and accurate filing of all tax-related documents and reports.
  • Preparation and/or review of quarterly and annual income tax provisions in accordance with ASC 740 (formerly FAS 109) and other relevant accounting standards.
  • Ensure accurate calculation of current and deferred tax assets and liabilities.
  • Review and analyze tax provision workpapers, including tax adjustments and deferred tax calculations.
  • Implement best practices for tax provision and financial reporting.
  • Prepare SOX documentation associated with financial statement provision.
  • Coordinate with financial statement auditors.
  • Prepare for and manage tax audits, ensuring that all documentation is accurate and available.
  • Address and resolve any audit findings or issues.
  • Develop and implement tax strategies to optimize tax positions and minimize liabilities.
  • Monitor changes in tax laws and regulations that may impact the tax provision process and financial reporting.
  • Conduct tax research and analysis to provide guidance on complex tax issues.
  • Advise on tax implications of business decisions, transactions, and strategies.
  • Manage the preparation and filing of indirect tax returns, including VAT, sales tax, excise duties, and other applicable taxes.
  • Ensure timely and accurate compliance with all indirect tax regulations and requirements across different jurisdictions.
  • Maintain up-to-date knowledge of indirect tax laws and regulations to ensure compliance and to identify potential opportunities or risks.
  • Conduct tax research and analysis to support business decisions and ensure tax efficiency.
  • Maintain accurate and organized documentation to support indirect tax compliance and audit requirements.
  • Coordinate with team members and other departments to ensure accurate financial reporting and tax compliance.
  • Manage relationships with external tax advisors and auditors.

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates by maximizing the potential of these candidates through a combination of in-house development and strategic partnerships, which helps build a strong pipeline of drugs. One of its key subsidiaries, Genevant, specializes in RNA therapeutics, utilizing proprietary delivery platforms for mRNA, RNAi, and gene editing to create effective treatments for specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

New York City, New York

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

-11%
Simplify Jobs

Simplify's Take

What believers are saying

  • Roivant's recent $7.1B deal with Roche to acquire Telavant highlights its strong potential for lucrative partnerships and significant financial growth.
  • The company's diverse pipeline, including promising RNA therapeutics and gene editing technologies, offers substantial opportunities for breakthrough treatments.
  • Strategic investments, such as the $2.02 million from Exchange Traded Concepts LLC, indicate strong investor confidence and financial stability.

What critics are saying

  • The failure of the lupus drug brepocitinib in Phase 2 trials underscores the inherent risks in drug development and potential setbacks.
  • Rumors of acquiring Immunovant, Inc. could lead to financial strain and integration challenges if not managed properly.

What makes Roivant Sciences unique

  • Roivant Sciences leverages a unique business model that combines in-house product development with strategic partnerships, setting it apart from traditional biopharmaceutical companies.
  • The company's focus on RNA therapeutics and genetic disorders, particularly through its subsidiary Genevant, positions it at the forefront of cutting-edge medical treatments.
  • Roivant's ability to rapidly advance its drug pipeline and form strategic alliances allows it to bring innovative treatments to market more quickly and efficiently than many competitors.

Help us improve and share your feedback! Did you find this helpful?